LIM
Lagoda Investment Management Portfolio holdings
AUM
$177M
This Quarter Return
-8.37%
1 Year Return
+46.81%
3 Year Return
+194.86%
5 Year Return
+427.13%
10 Year Return
+1,154.94%
AUM
$305M
AUM Growth
+$305M
(-19%)
Cap. Flow
-$32.5M
Cap. Flow
% of AUM
-10.64%
Top 10 Holdings %
Top 10 Hldgs %
71.41%
Holding
35
New
2
Increased
10
Reduced
13
Closed
5
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
$10.7M |
| 2 |
TTOO
T2 Biosystems, Inc
TTOO
|
$6.66M |
| 3 |
Precigen
PGEN
|
$6.15M |
| 4 |
VolitionRX
VNRX
|
$5.72M |
| 5 |
Baidu
BIDU
|
$4.42M |
Top Sells
| 1 |
Berkshire Hathaway Class A
BRK.A
|
$23.3M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$12.7M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$9.23M |
| 4 |
Novo Nordisk
NVO
|
$8.62M |
| 5 |
Allison Transmission
ALSN
|
$8.22M |
Sector Composition
| 1 | Healthcare | 50.22% |
| 2 | Technology | 18.73% |
| 3 | Communication Services | 10.91% |
| 4 | Financials | 10.46% |
| 5 | Materials | 5.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Pfizer
PFE
$141B
| $46K | 0.02% |
1,537
-80
| -5% | -$2.39K |
|
27
AbbVie
ABBV
$372B
| $28K | 0.01% |
491
| – | – |
|
28
Abbott
ABT
$231B
| $27K | 0.01% |
640
| – | – |
|
29
Phillips 66
PSX
$54B
| $17K | 0.01% |
197
| – | – |
|
30
GSK
GSK
$79.9B
| $7K | ﹤0.01% |
174
-65
| -27% | -$2.62K |
|
31
Bausch Health
BHC
$2.74B
| – | – |
-12,969
| Closed | -$1.32M |
|
|
32
Berkshire Hathaway Class B
BRK.B
$1.09T
| – | – |
-32,945
| Closed | -$4.35M |
|
33
Johnson & Johnson
JNJ
$427B
| – | – |
-69,400
| Closed | -$7.13M |
|
|
GOLD
34
DELISTED
Randgold Resources Ltd
GOLD
| – | – |
-1,500
| Closed | -$93K |
|
|
35
Allison Transmission
ALSN
$7.3B
| – | – |
-317,333
| Closed | -$8.22M |
|